3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Lung Neoplasms
16
Prostatic Neoplasms
12
Colorectal Neoplasms
12
Hematologic Neoplasms
7
Hematopoietic and Lymphatic System Neoplasm
6
Neoplasms
5
Neoplasm Metastasis
5
Lymphoma
5
Ovarian Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Fatigue
3
Anatomic Stage I Breast Cancer AJCC v8
3
Advanced Malignant Solid Neoplasm
3
Uterine Cervical Neoplasms
2
Skin Carcinoma
2
Papillomavirus Infections
2
Malignant Solid Neoplasm
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Gastrointestinal Neoplasms
2
Interventions
Cyclophosphamide
51
fludarabine
37
Dexamethasone
35
venetoclax
30
pembrolizumab
25
Rituximab
20
pomalidomide
18
Lenalidomide
17
Gemcitabine
17
fludarabine phosphate
15
Etoposide
14
Cytarabine
13
daratumumab
12
carfilzomib
11
Temozolomide
11
Injections
10
Calcium Dobesilate
10
glofitamab
9
Nivolumab
9
Cisplatin
9
Bortezomib
9
Azacitidine
9
selinexor
8
Vincristine
8
Immunotherapy, Adoptive
8
obinutuzumab
7
cemiplimab
7
Drug Therapy
7
Carboplatin
7
zanubrutinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Educational Status
×
1 year
×
Clear all
No trials found.